Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-related Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03466177
What this trial is testing

Multimodal Retinal Imaging in the Detection and Follow-up of Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAlzheimer DementiaMild Cognitive Impairment+4 more
Universitaire Ziekenhuizen KU Leuven 320
Not applicableLooking for participantsNCT06843499
What this trial is testing

Effectiveness and Cost-Effectiveness Evaluations of AI-Assisted Diagnostic Software (VeriSee) for Ophthalmic Disease Screening

Who this might be right for
Age-Related Macular Degeneration (AMD)Diabetic Retinopathy (DR)
National Taiwan University Hospital 1,000
Not applicableStudy completedNCT00797095
What this trial is testing

Health Behaviors in School-age Children: 2009-2010

Who this might be right for
ObesitySubstance AbuseViolence+1 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 12,651
Early research (Phase 1)Study completedNCT00320775
What this trial is testing

Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD

Who this might be right for
Macular Degeneration
Regeneron Pharmaceuticals 51
Post-approval studies (Phase 4)Study completedNCT01986907
What this trial is testing

Safety and Tolerability of Ranibizumab in Mono/Bilateral Wet Age Related Macular Degeneration (w-AMD) Patients in Eyes With BCVA<2/10 and/or 2nd Affected Eye

Who this might be right for
Wet Age Related Macular Degeneration
Novartis Pharmaceuticals 1,049
Early research (Phase 1)Study completedNCT00500344
What this trial is testing

CAPTAIN:Choroidal Neovascularization Assessment by Pattern Electroretinography

Who this might be right for
Age-related Macular Degeneration
Washington University School of Medicine 17
Testing effectiveness (Phase 2)Study completedNCT00511706
What this trial is testing

Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationAge-Related Maculopathy
Allergan 243
Testing effectiveness (Phase 2)Ended earlyNCT02228304
What this trial is testing

Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Neurotech Pharmaceuticals 42
Not applicableStudy completedNCT05110209
What this trial is testing

Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Agerelated Macular Degeneration (AMD) Who Received Anti-VEGF Agents (IRIS Registry)

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals 331,541
Large-scale testing (Phase 3)Study completedNCT02081898
What this trial is testing

Effects of Long Term Calorie Restriction on Sphingomyelin and Amino Acids

Who this might be right for
OverweightObese
Yonsei University 120
Not applicableStudy completedNCT01590706
What this trial is testing

Characterizing Cognitive Decline and Functional Cardiac Senescence in Healthy Korean Volunteers

Who this might be right for
AgingMild Cognitive ImpairmentAngina Pectoris
Korea Institute of Oriental Medicine 116
Testing effectiveness (Phase 2)Ended earlyNCT05893537
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).

Who this might be right for
Age-Related Macular Degeneration
Cognition Therapeutics 100
Not applicableStudy completedNCT04724395
What this trial is testing

Disability Following Hospitalization in People of Working-age Surviving SARS-CoV-2 Infection - COVID-19

Who this might be right for
COVID-19
Assistance Publique - Hôpitaux de Paris 530
Testing effectiveness (Phase 2)UnknownNCT01521065
What this trial is testing

An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationWet Macular DegenerationMacular Degeneration+2 more
Oraya Therapeutics, Inc. 500
Not applicableStudy completedNCT02488863
What this trial is testing

NEPAL (Neuromodulatory Examination of Pain and Mobility Across the Lifespan)

Who this might be right for
Musculoskeletal PainPain, Chronic
University of Florida 105
Not applicableStudy completedNCT04482465
What this trial is testing

Omega 3 and Vitamin D Dosage in a Population With Moderate to High Risk of AMD

Who this might be right for
Age-related Macular DegenerationVitamin D Deficiency
Universitaire Ziekenhuizen KU Leuven 50
Large-scale testing (Phase 3)Ended earlyNCT04757636
What this trial is testing

OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Opthea Limited 998
Not applicableStudy completedNCT06145295
What this trial is testing

The Effectiveness of an Online Support Group in Enhancing Recovery Identity and Health-Related Quality of Life

Who this might be right for
Ovarian Cancer
Shanghai Jiao Tong University School of Medicine 68
Early research (Phase 1)Study completedNCT00407719
What this trial is testing

Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationDegenerative MyopiaPathological Myopia
Johns Hopkins University 10
Not applicableUnknownNCT04142164
What this trial is testing

Computer-based Tutorial and Automated Speech Recognition for Intravitreal Drug Injections

Who this might be right for
Age-related Macular DegenerationRetinal Vein OcclusionDiabetic Macular Edema
Prim. Prof. Dr. Oliver Findl, MBA 40
Next Page